18th EFMC Short Course on Medicinal Chemistry
Transformative Approaches in Medicinal Chemistry, with Applications in Cancer Research
EFMC Symposium
Oegstgeest (near Leiden), The Netherlands
Course Outline:
Technologies for drug discovery are constantly evolving. Significant developments within the last 20 years range from the development of DNA-encoded libraries for hit finding and even hit-to-lead optimisation to the reinvigoration of irreversible inhibitors resulting in innovative oncology drugs such as osimertinib and sotorasib.
This course will cover advanced methods, new technologies and tools available for medicinal chemists, with a focus on oncology drug discovery, including fragment based-drug discovery, DNA-encoded library technologies, covalent drug discovery and small molecules that target RNA. The course will finish with a series of oncology case studies successfully utilising these drug discovery technologies for the development of clinical candidates and marketed drugs.
Course Organisers:
- Prof. Mike Waring (Newcastle University, United Kingdom)
- Dr Hannah Stewart (Newcastle University, United Kingdom)
Local Organiser:
- Prof. Laura Heitman (Leiden University, The Netherlands)
RSC-BMCS 35th Medicinal Chemistry in Eastern England
EFMC Sponsored Event
Stevenage, United Kingdom
Known colloquially as the “Hatfield MedChem” meeting*, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.
To register, please follow this link.